InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,006.45
(
1.15%
)
Post# of 2342225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mick Dodge

Send PM Follow Ignore
Followers 580
Posts 61808
Boards Moderated 3
Alias Born 03/02/2010

Mick Dodge

Re: None

Thursday, 05/28/2015 9:33:55 AM

Thursday, May 28, 2015 9:33:55 AM

Post# of 2342225
Compensated Awareness Post View Disclaimer
$MYOS news out! CEDAR KNOLLS, NJ--(Marketwired - May 28, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance, announced today that Health Canada, has reviewed and approved Fortetropin®, the Company's proprietary ingredient, for sale in powder dose form in Canada. Fortetropin is the first fertilized egg yolk powder ingredient to be approved by Health Canada and issued a Natural Product Number.

IF YOU LIKE THE CHARTS HIT ME UP WITH A PERSON MARK
http://investorshub.advfn.com/boards/profilea.aspx?user=192141

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up